SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Tularik Inc. (TLRK)
An SI Board Since October 1999
Posts SubjectMarks Bans Symbol
598 27 0 TLRK
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
498>> Anyone know how much of Rinat TLRK had prior to yesterday's financiscaram(o)uche-8/20/2003
497Anyone know how much of Rinat TLRK had prior to yesterday's financing ? Mesnigel bates-8/20/2003
496Tularik Receives Two National Cancer Institute Grants to Develop New Cancer Therscaram(o)uche-8/12/2003
495GS report: Stock rating: In-Line Coverage view: Neutral Small-Cap Growth Price:mopgcw-7/25/2003
494FEBS Lett. 2003 Jul 17;547(1-3):157-61. Characterization of Pellino2, a substscaram(o)uche-7/17/2003
4934:10PM Tularik misses by $0.08 (TLRK) 11.27 -0.33: Reports Q2 (Jun) loss of $0.5Czechsinthemail-7/16/2003
492TLRK reports, with a few nuggets re ZKB and Amgen: >>SOUTH SAN FRANCISCO,tuck-7/16/2003
491Tularik's Ling on 'Which Genome' (posted elsewhere by tuck) : dddmanigel bates-7/15/2003
490they must be dumping today. price holding up well on the volume.mopgcw-7/9/2003
489George, By my calculations, Zurich CantonBank has about 1.8 million shares lefttuck-6/29/2003
488ZKB has been dumping blocks over the course of the month. will be interesting tmopgcw-6/29/2003
487seems to be a buyer in volume this morning...mopgcw-6/27/2003
486Wachovia replay: corporate-ir.net Note WAC dropped biotech coverage given analmopgcw-6/26/2003
485Tularik Expects to Sell Liver-Cancer Drug in 2007, Goeddel Says June 10 (Bmopgcw-6/26/2003
484Abstract Number: 588-P Authors: JOHN A. WAGNER, XUN CHUN, RONDA K. RIPPLEY, Jkeokalani'nui-6/16/2003
483GS report: Stock rating: In-Line Coverage view: Neutral Small-Cap Growth Price:mopgcw-6/13/2003
482Proc Natl Acad Sci U S A. 2003 Jun 2 [Epub ahead of print] Oncogenic potential scaram(o)uche-6/12/2003
481ceo to be on bloomberg tv this morning 10:40 am.mopgcw-6/10/2003
480<duplicate>Czechsinthemail-6/6/2003
479<i>On May 21, 2003, Amgen and the Issuer entered into a Collaboration AgreCzechsinthemail-6/6/2003
478Item 4. Purpose of Transaction. From time to time in the past, where circumsscaram(o)uche-6/5/2003
477>>WASHINGTON -(Dow Jones)- Amgen Inc. (NasdaqNM:AMGN - News) said discussituck-6/5/2003
476per WUWT on the fireworks thread... STAMFORD, Conn., June 3 /PRNewswire-FirstCanigel bates-6/3/2003
475GS on TLRK/AMGN: Stock rating: In-Line Coverage view: Neutral Small-Cap Growthmopgcw-5/23/2003
474I'm sorry, but you've just got to stop pumping these pieces of microcap nigel bates-5/21/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News